 |
| PZOO LOI with Former Mr. America |
|
 Yesterday's Top Performer |
Company: Marley Coffee (OTCBB: JAMN)
|
End of Day:
Price: 0.15
Change (%): + 0.005 (3.45)
Volume: 62,473 |
 |
Marley Coffee is a US-based company providing premium-roasted coffee to the Grocery, Retail, Online, Service/Hospitality, Office Coffee Service, and Big Box Store industries. Under its exclusive licensing agreement with 56 Hope Road (Bob Marley Museum), the Company continues to develop its coffee lines under the Marley Coffee brand. Marley Coffee is a fully reporting company quoted on the OTCBB under the symbol JAMN.
Marley Coffee's gourmet product line is positioned for the significant trend and growing consumer awareness towards organic, fairly traded premium, and super premium specialty coffees.
Continue Reading
|
Company: Mantra Venture Group Ltd. (OTCBB: MVTG)
|
End of Day:
Price: 0.23
Change (%): + 0.01 (4.55)
Volume: 118,750 |
 |
Mantra Venture Group Ltd.'s primary operating business is Mantra Energy Alternatives Ltd, a wholly owned subsidiary. Mantra's mission is to become the world leader in the production of high value, carbon negative chemicals and fuels. Its ERC system will reduce the problem greenhouse gas carbon dioxide (CO2) and convert it into a series of valuable chemicals, a form of carbon capture and recycling (CCR). There are currently 27 billion metric tons of CO2 emitted annually from fossil fuel combustion, providing an inexhaustible supply of feedstock.
Continue Reading
|
 Hot Stock to Watch
|
Company: Pazoo, Inc. (OTCBB: PZOO)
|
End of Day:
Price: 0.0375
Change (%): - 0.0025 (6.25)
Volume: 35,500 |
 |
Pazoo, Inc., Signs Letter of Intent with Celebrity Trainer, Dean Tornabene
CEDAR KNOLLS, N.J., Nov. 12, 2012 /PRNewswire/ - Pazoo, Inc., (OTCBB Symbol: PZOO) (German WKN#: A1J3DK) is pleased to announce the signing of a letter of intent with Dean Tornabene, a celebrity trainer who is known as the trainer to the stars. Dean is a former Mr. America, professional bodybuilder, and national powerlifting champion. Furthermore, he has designed award winning patented exercise products, food supplements, and weight control products. Dean's background makes him a natural fit to work with Pazoo.
Dean Tornabene and his company, Design by Dean, Inc., will make an immediate impact with Pazoo. Pazoo's relationship with Design by Dean, will extend from Dean being an expert on the health and wellness expert panel to promoting Pazoo's products.
Continue Reading |
Other Small Cap News
|
Company: Get Real USA, Inc. (Pink Sheets: GTRL)
|
Get Real USA (GTRL) Achieves Key Milestones Towards Building a Vertically Integrated Movie Production, Distribution and Finance Company
BEVERLY HILLS, Calif., Nov. 12, 2012 /PRNewswire/ - Get Real USA, Inc. (PINKSHEETS: GTRL) announced significant inroads towards achieving their ultimate goal of becoming a vertically integrated movie producer, distributor and financer.
Frank Weber, President and CEO of Get Real USA said, "Our goal is to fill the market void in getting high quality low-budget films financed, produced and distributed. We believe this direction will be extremely profitable for GTRL, given the seemingly insatiable appetite for new video content worldwide."
Continue Reading
|
Company: BacTech Environmental Corporation (OTCBB: BCCEF)
|
BacTech Obtains OTC Pink Sheet Listing in U.S.
TORONTO, CANADA-(Marketwire - Nov. 12, 2012) - BacTech Environmental Corporation ("BacTech" or the "Company") (CNSX:BAC) (OTC:BCCEF) (WKN:A1H4TY) today announced that the Company's shares have been approved for trading in the United States.
The Company received notice from its sponsoring broker, Pennaluna and Company ("Pennaluna"), that its shares will be quoted on the OTC Pink Sheets in the U.S. as of November 8. Pennaluna will be the market maker for the common shares of BacTech, which will trade under the symbol "BCCEF".
Continue Reading |
Company: Amarantus BioSciences, Inc. (OTCQB: AMBS)
|
Amarantus BioSciences Appoints Dr. Robert J. Zimmerman as Product Development Advisor
SUNNYVALE, Calif., Nov. 12, 2012 /PRNewswire/ - Amarantus BioSciences, Inc. (OTCQB: AMBS), a biotechnology company developing new treatments and diagnostics for Parkinson's disease and Traumatic Brain Injury centered on its proprietary anti-apoptosis therapeutic protein MANF, today announced that it has appointed Robert J. Zimmerman, SD as product development advisor. In Dr. Zimmerman's advisory role, he will assist Amarantus management with expansion of the Company's MANF product development strategy. Dr. Zimmerman will also assist in the procurement of relationships with top-tier vendors to ensure that state-of-the art development data are gathered with high quality test article materials. Amarantus expects to gather data in additional indications through its research grant with the Center of Excellence in Apoptosis Research, collaboration with highly-respected academic labs, and through outsourcing efficacy and toxicology studies with independent contract labs.
Continue Reading |
Market News
|
By Holly Ellyatt and Kelly Evans: CNBC
|
Greece's 'Monster' Debt Problem Haunts Europe
Euro zone finance ministers meeting in Brussels on Monday won't make a final decision on aid for Greece, despite Athens passing a new austerity budget. But one former European Central Bank (ECB) official has told CNBC that Europe must give Athens more time.
Urging Europe to extend Greece's debt maturities, former ECB board member Lorenzo Bini Smaghi told CNBC that it was a critical moment for Europe to help and not hinder Greece.
"Greece was asked to do a series of things that they have done. Now it's the rest of Europe that needs to find a solution and help Greece come out from this situation," he said, stating that there were several options available to Europe to assist Greece.
Continue Reading
|
By Jeff Macke: Breakout
|
Fiscal Cliff Negotiations: A Process Sure to Enrage All Americans
Last week's election results were largely as expected. The President won reelection, Democrats still have a majority in the Senate, and Republicans control the House of Representatives. The only surprise was the brutally negative reaction of Wall Street.
Ed Mills of FBR Capital Markets says the risk of going off the fiscal cliff went up last week, in part explaining some of the negativity among traders. Mills says both sides have reason to believe they will prevail in a showdown based on the results, encouraging them to dig into their positions as the arguing and horse trading pick up steam into the new year.
Democrats can point to the President's victory as evidence that the public is backing his "tax the rich" posturing. Republicans have exit polling data showing 63% of the public oppose new taxes, emboldening them despite Romney's loss. Speaker Boehner and the President are making the right conciliatory noises, but without the backing of the rank and file it doesn't matter.
Continue Reading
|
  |
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the "unsubscribe" link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks |
|
|
